All bills
H.R. 4076·118th Congress·House Bill

United States-Israel Health Technologies Cooperation Act

Stage not supplied

The source supplies the latest action, but no lifecycle stage.

Latest action (16 Jun 2023): Referred to the Subcommittee on Health.

What this bill does

H.R. 4076, the United States-Israel Health Technologies Cooperation Act, would authorize funding for a joint program between the United States and Israel focused on developing health technologies. Specifically, it allows for $4 million annually for fiscal years 2024 through 2026 to be appropriated to the Secretary of Health and Human Services. This funding would be used for grants to advance health technologies, with a focus on using technology, personalized medicine, and data to address emerging infectious diseases. Examples of technologies include artificial intelligence, drugs, vaccinations, respiratory devices, diagnostic tests, and telemedicine.

This program would affect entities involved in health technology development in both countries. A key provision is that any funding under this act requires a matching contribution from the Israeli government. The bill also outlines that the program could either build upon an existing bilateral program or establish a new one in consultation with the Secretary of State, potentially under a previous science and technology cooperation agreement.

The bill was introduced in the House of Representatives on June 13, 2023, and currently has the status of "Introduced." It was referred to the Committee on Energy and Commerce. In a previous session of Congress, a similar bill was introduced but did not receive a vote. For H.R. 4076 to advance, it would need to be considered and potentially passed by the House committee, then by the full House, and subsequently go through the Senate legislative process.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Timeline

  1. 16 Jun 2023

    Referred to the Subcommittee on Health.

Common questions

What does H.R. 4076 do?
H.R. 4076, the United States-Israel Health Technologies Cooperation Act, would authorize funding for a joint program between the United States and Israel focused on developing health technologies. Specifically, it allows for $4 million annually for fiscal years 2024 through 2026 to be appropriated to the Secretary of Health and Human Services. This funding would be used for grants to advance health technologies, with a focus on using technology, personalized medicine, and data to address emerging infectious diseases. Examples of technologies include artificial intelligence, drugs, vaccinations, respiratory devices, diagnostic tests, and telemedicine. This program would affect entities involved in health technology development in both countries. A key provision is that any funding under this act requires a matching contribution from the Israeli government. The bill also outlines that the program could either build upon an existing bilateral program or establish a new one in consultation with the Secretary of State, potentially under a previous science and technology cooperation agreement. The bill was introduced in the House of Representatives on June 13, 2023, and currently has the status of "Introduced." It was referred to the Committee on Energy and Commerce. In a previous session of Congress, a similar bill was introduced but did not receive a vote. For H.R. 4076 to advance, it would need to be considered and potentially passed by the House committee, then by the full House, and subsequently go through the Senate legislative process.
Has H.R. 4076 become law?
The source does not supply a confirmed lifecycle stage for H.R. 4076. Check the latest action and official source below.
Who sponsored H.R. 4076?
H.R. 4076 was sponsored by Rep. Pappas, Chris [D-NH-1] (D-NH), with 67 cosponsors.
What's the latest action on H.R. 4076?
Referred to the Subcommittee on Health. (16 Jun 2023).

Related bills in Health

More bills from Rep. Pappas, Chris [D-NH-1]

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.